Related Experiment Videos
HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient
Clare L Ross1, Beverley J Hunt, Duncan Wyncoll
1Department of Intensive Care, Guy's and St Thomas' NHS Trust, St Thomas' Hospital, London, UK.
HIV is an increasingly common cause of thrombotic thrombocytopaenic purpura in the United Kingdom. We report a patient with both conditions who presented major therapeutic and ethical challenges. Furthermore, he was recalcitrant to all established therapies, and was, therefore, the first reported HIV patient with thrombotic thrombocytopaenic purpura to receive rituximab.
HIV is an increasingly common cause of thrombotic thrombocytopaenic purpura in the United Kingdom. We report a patient with both conditions who presented major therapeutic and ethical challenges. Furthermore, he was recalcitrant to all established therapies, and was, therefore, the first reported HIV patient with thrombotic thrombocytopaenic purpura to receive rituximab.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy
Myocarditis III: Medical Management